| ||
| ||
| ||
| This year the Relay hits closer to home Hancock County Journal Pilot My parents, grandparents, aunts and uncles, my brother and several friends, they've all been affected by cancer. "This year it hits much closer to home." This year Leon will have just finished his final radiation treatment for lung cancer on Monday ... See all stories on this topic » | ||
| Cancer Survivor Celebration Indianapolis Star (blog) Lynn Sherr, ABC and 20/20 news correspondent, who is also a cancer survivor, will share her personal story of cancer survivorship. She'll also talk about her experience witnessing news anchor Peter Jennings' battle with lung cancer. He died in 2005. ... See all stories on this topic » | ||
| Bio-Nucleonics Continues Production of Cancer Drug Business Wire (press release) Strontium-89 is an intravenously administered cancer drug that provides long lasting pain relief for patients suffering from bone pain due to metastatic cancer, typically caused by advanced stage breast, prostate or lung cancer. ... See all stories on this topic » | ||
| NIH study finds experimental drug benefits patients with rare type of cancer Media Newswire (press release) ... has tested the effect of cediranib in treating a variety of tumors, including lung and colorectal cancers, but ASPS is the first solid tumor that has demonstrated substantial tumor shrinkage. NCI's Division of Cancer Treatment and Diagnosis ( DCTD ... See all stories on this topic » | ||
| ||
| ASCO Pops and Drops Motley Fool Cabozantinib is a little behind the curve, especially in prostate cancer treatment, which is getting fairly crowded. But that's not a new issue, so I don't understand why it would cause investors to hit the sell button. Biotech is already a volatile ... See all stories on this topic » |
| ||
| Research Creates Nanoparticles Perfectly Formed to Tackle Cancer ... Scientists at the University of Granada have developed a new therapy for the treatment of skin and lung cancer. This therapy involves the use of a suicide coliphage-gene (gene E) … ... ScienceNewsline - top news | ||
| Interim results from Cyclacel clinical study highlight safety and ... By Kim Chapman Seliciclib (CYC202 or R-roscovitine), a CDK (cyclin dependent kinase) inhibitor, is in Phase 2 studies for the treatment of lung cancer and nasopharyngeal cancer and in a Phase 1 trial in combination with sapacitabine. ... IEWY Press Release Distribution |
| ||
| seven questions and answers to lung cancer treatment A range of factors decide the course of treatment for lung cancer. ... These medication may not cure lung cancer but could improve the standard of the ... www.articlesmonstrous.com/Article/seven...and.../107890 | ||
| Extending Alimta Treatment Delays Lung Cancer Progression ... For patients with advanced, nonsquamous, non-small cell lung cancer who receive Alimta® (pemetrexed) as part of their initial treatment, ... www.caring4cancer.com/go/cancer/news?NewsItemId=45310 | ||
| alternative treatment for lung cancer can help to overcome | Lung ... One of the best ways to fight the bad news that you have lung cancer is by employing some cancer cures and prevention in your daily life. lungcancertreatment.sitesoom.com/alternative-treatment-for-lu... |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment